{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"155-334-057-258-127","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"155-334-057-258-127","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":8902,"type":"PATENT","title":"University of Tokyo Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":20983,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8217,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search applicants and owners = \"Univ Tokyo\", \"Univ Tokyo NOT metropolitan\", \"Tokyo Univ\",\"University of Tokyo NOT metropolitan\", \"Tokyo Univ\".
Select more for logical variants
Add to collection
Total patent: 13934
Search applicants and owners = \"Univ Tokyo\", \"Univ Tokyo NOT metropolitan\", \"Tokyo Univ\",\"University of Tokyo NOT metropolitan\", \"Tokyo Univ\".
Select more for logical variants
Add to collection
Total patent: 13934
administering a pharmaceutical composition comprising a purified bacterial mixture of at least two live bacterial strains belonging to Clostridium clusters IV and/or XIVa to the human subject, wherein the bacterial strains are spore-forming bacteria and are isolated from a human."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the autoimmune disease is organ transplant rejection, inflammatory bowel disease (IBD), ulcerative colitis, Crohn's disease, sprue, rheumatoid arthritis, Type 1 diabetes, graft versus host disease, or multiple sclerosis."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 2, wherein the autoimmune disease is inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the at least two live bacterial strains belonging to Clostridium clusters IV and/or XIVa comprise two or more strains belonging to Clostridium cluster IV."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the at least two live bacterial strains belonging to Clostridium clusters IV and/or XIVa comprise two or more strains belonging to Clostridium cluster XIVa."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the at least two live bacterial strains belonging to Clostridium clusters IV and/or XIVa comprise one or more strains belonging to Clostridium cluster IV and one or more strains belonging to Clostridium cluster XIVa."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the bacteria are isolated from a chloroform-treated human fecal sample."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the pharmaceutical composition comprises a pharmaceutically acceptable excipient."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the pharmaceutical composition is administered orally."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the pharmaceutical composition is formulated for delivery to the intestine."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 10, wherein the pharmaceutical composition comprises a pH sensitive composition comprising one or more enteric polymers."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 10, wherein the pharmaceutical composition is in the form of a capsule."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the bacteria are in the form of spores."],"number":13,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}